Skip to content
Back
Most recent
TGA approves Eylea
The TGA has approved a new drug, Eylea, for the treatment of wet (neovascular) age-related macular degeneration.
Audio description trial
ABC to trial audio description on television to assist people who are blind or visually impaired.
Judi Dench shares AMD diagnosis
Dame Judi Dench has revealed a diagnosis of age-related macular degeneration.
Postcard campaign success
The federal government has heard and acknowledged the Foundation’s postcard campaign for increased funding.
CATT study raises questions
We reviewed the results of the CATT study, designed to compare two drugs Lucentis (ranibizumab) and Avastin (bevacizumab) used to treat wet AMD.
Inaugural research grants awarded
The inaugural Macular Degeneration Foundation Research Grants Program awarded nearly three-quarters of a million dollars to support crucial macular disease research.
Eyes on the future
The 2011 Eyes on the Future report provides the most comprehensive compilation of macular degeneration statistics and research ever undertaken in Australia.
Hyperbaric oxygen treatment
There is no compelling evidence-based research that hyperbaric oxygen treatment has a beneficial effect on AMD.
Inaugural mEYE World winners
MDFA’s first ever mEYE World competition invited people to help raise awareness of AMD through photography.